Cargando…

Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease

Stroke is a common and devastating condition caused by atherothrombosis, thromboembolism, or haemorrhage. Patients with chronic coronary syndromes (CCS) or peripheral artery disease (PAD) are at increased risk of stroke because of shared pathophysiological mechanisms and risk-factor profiles. A rang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parker, William A E, Gorog, Diana A, Geisler, Tobias, Vilahur, Gemma, Sibbing, Dirk, Rocca, Bianca, Storey, Robert F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916419/ https://www.ncbi.nlm.nih.gov/pubmed/33664637 http://dx.doi.org/10.1093/eurheartj/suaa165

Ejemplares similares

Antithrombotic therapy in diabetes: which, when, and for how long?
por: Ajjan, Ramzi A, et al.
Publicado: (2021)

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)

Spontaneous Coronary Artery Dissection: The Phantom Menace
por: Spinthakis, Nikolaos, et al.
Publicado: (2016)

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review
por: Farag, Mohamed, et al.
Publicado: (2022)

De-Escalation of P2Y(12) Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
por: Kupka, Danny, et al.
Publicado: (2018)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
por: Claassens, Daniel MF, et al.
Publicado: (2020)

MI with Non-obstructive Coronary Artery Presenting with STEMI: A Review of Incidence, Aetiology, Assessment and Treatment
por: Gue, Ying X, et al.
Publicado: (2020)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

A rare cause of myocardial infarction with non-obstructive coronary arteries—case report of ST-segment elevation myocardial infarction caused by a mediastinal mass
por: Gue, Ying X, et al.
Publicado: (2018)

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
por: Gorog, Diana A., et al.
Publicado: (2022)

Effect of genotype-guided strategy in East Asian vs. Caucasian patients after percutaneous coronary intervention: insight from the TAILOR-PCI trial
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease
por: Farag, Mohamed, et al.
Publicado: (2016)

Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes
por: Farag, Mohamed, et al.
Publicado: (2015)

Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
por: Walker, Jaqui, et al.
Publicado: (2020)

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement
por: Gorog, Diana A., et al.
Publicado: (2020)

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
por: Aradi, Dániel, et al.
Publicado: (2014)

Peripheral Artery Disease and Stroke
por: Zito, Concetta, et al.
Publicado: (2020)

Resveratrol-Coated Balloon Catheters in Porcine Coronary and Peripheral Arteries
por: Kamann, Stefanie, et al.
Publicado: (2019)

A case of repetitive myocardial infarction with unobstructed coronaries due to Churg–Strauss syndrome
por: Gue, Ying X, et al.
Publicado: (2019)

Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
por: Vilahur, Gemma, et al.
Publicado: (2014)

New Antithrombotic Drugs in Acute Coronary Syndrome
por: Zwart, Bastiaan, et al.
Publicado: (2020)

An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease
por: Katsanos, Aristeidis H., et al.
Publicado: (2021)

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis
por: Memtsas, Vassilios P., et al.
Publicado: (2021)

Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations
por: Lee, Sang Yeub, et al.
Publicado: (2023)

Incidence of thrombotic complications in COVID-19: On behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium
por: Jenner, William J., et al.
Publicado: (2021)

Bare Metal Stents on Resveratrol-Coated Balloons in Porcine Coronary and Peripheral Arteries
por: Kamann, Stefanie, et al.
Publicado: (2021)

Peripheral Artery Disease as a Predictor of Coronary Artery Disease in Patients Undergoing Coronary Angiography
por: Kumar, Ashok, et al.
Publicado: (2021)

Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score
por: Mittal, Tarun K., et al.
Publicado: (2017)

Moyamoya Disease with Peripheral Pulmonary Artery Stenoses and Coronary Artery Fistulae
por: Reardon, Lindsay, et al.
Publicado: (2009)

Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease
por: Gibler, W. Brian
Publicado: (2018)

Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications
por: Gorog, Diana A.
Publicado: (2018)

Atherosclerosis and Thrombosis: Insights from Large Animal Models
por: Vilahur, Gemma, et al.
Publicado: (2011)

The platelet paradox of injury versus protection in myocardial infarction—has it been overlooked?
por: Kleinbongard, Petra, et al.
Publicado: (2021)

Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
por: Schoch, Leonie, et al.
Publicado: (2021)

Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
por: Barriuso, Ignacio, et al.
Publicado: (2022)

Mechanisms of Chronic State of Inflammation as Mediators That Link Obese Adipose Tissue and Metabolic Syndrome
por: Fuentes, Eduardo, et al.
Publicado: (2013)

Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease
por: Cowie, Martin R, et al.
Publicado: (2020)

Peripheral Artery Disease Diagnosed by Pulse Palpation as a Predictor of Coronary Artery Disease in Patients with Chronic Kidney Disease
por: Dos Santos, Daniel B. C., et al.
Publicado: (2023)

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences
por: Kim, Hyun Kuk, et al.
Publicado: (2021)

Interventional Treatment for Stroke Prevention
por: Gianni, Carola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ls4na6fo3oeot1rgh9af9uqcd2